Results 151 to 160 of about 31,694,594 (321)

Insights into Flow and Continuous Systems in Pharmaceutical Manufacturing: Challenges and Opportunities. [PDF]

Org Process Res Dev
Daly AM, Hardiman S, Hogan D, Morris G, Moylan R, O'Donovan B, Power E, Phillips P, Robinson S, Roth PMC, Smyth M, Magner E, Arthur A, McGlacken GP, Baumann M, Maguire AR.   +15 more
europepmc   +1 more source

Non-linear Continuous Systems for Safety Verification

ARCH@CPSWeek, 2016
A. Sogokon, Khalil Ghorbal, Taylor T. Johnson   +2 more
semanticscholar   +1 more source

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Acetaminophen and Tetracycline Removal Using <i>Prosopis juliflora</i>-Derived ZnO-Modified Biochar: Evaluation in Batch and Continuous Systems. [PDF]

ACS Omega
Singanodi Vallabha M, Asma SR, Reddy R, Mohan B, Girish CR.   +4 more
europepmc   +1 more source

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte, Lucy Norcliffe‐Kaufmann, Maria Luisa Cotrina, Zenith Khan, Kaia Dalamo, Patricio Millar Vernetti, Matthew Lawless, Elisabetta Morini, Monica Salani, Marla Weetall, Jana Narasimhan, Agostino G. Rocha, Susan A. Slaugenhaupt, Horacio Kaufmann   +13 more
wiley   +1 more source

Evolution and Future of Glucose Monitoring: From Blood Glucose Meters to Continuous Systems and Their Projected Impact in the Middle East and North Africa (MENA) Region. [PDF]

Cureus
Darkhabani O, Ahmed A.
europepmc   +1 more source

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky, Cara Joyce, H. Jeremy Bockholt, Paul A. Rudnick, William H. Adams, Fiona McAllister, Justin W. Smock, Michael A. Newton, Jane S. Paulsen   +8 more
wiley   +1 more source

Supervised optimal control in complex continuous systems with trajectory imitation and reinforcement learning. [PDF]

Sci Rep
Liu Y, Liu F, Huang R.
europepmc   +1 more source

Verified Reachability Analysis of Continuous Systems

International Conference on Tools and Algorithms for Construction and Analysis of Systems, 2015
Fabian Immler
semanticscholar   +1 more source

Glymphatic Dysfunction Reflects Post‐Concussion Symptoms: Changes Within 1 Month and After 3 Months

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Mild traumatic brain injury (mTBI) may alter glymphatic function; however, its progression and variability remain obscure. This study examined glymphatic function following mTBI within 1 month and after 3 months post‐injury to determine whether variations in glymphatic function are associated with post‐traumatic symptom severity ...
Eunkyung Kim, Han Gil Seo, Roh‐Eul Yoo, Byung‐Mo Oh   +3 more
wiley   +1 more source